Ronot X - Search Results

1

Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues.

Hadjeri M, Barbier M, Ronot X, Mariotte AM, Boumendjel A, Boutonnat J. Hadjeri M, et al. Among authors: ronot x. J Med Chem. 2003 May 22;46(11):2125-31. doi: 10.1021/jm021099i. J Med Chem. 2003. PMID: 12747785

2

Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).

Boumendjel A, Nicolle E, Moraux T, Gerby B, Blanc M, Ronot X, Boutonnat J. Boumendjel A, et al. Among authors: ronot x. J Med Chem. 2005 Nov 17;48(23):7275-81. doi: 10.1021/jm050705h. J Med Chem. 2005. PMID: 16279786

3

2-Arylidenedihydroindole-3-ones: design, synthesis, and biological activity on bladder carcinoma cell lines.

Gerby B, Boumendjel A, Blanc M, Bringuier PP, Champelovier P, Fortuné A, Ronot X, Boutonnat J. Gerby B, et al. Among authors: ronot x. Bioorg Med Chem Lett. 2007 Jan 1;17(1):208-13. doi: 10.1016/j.bmcl.2006.09.057. Epub 2006 Oct 16. Bioorg Med Chem Lett. 2007. PMID: 17049235

4

Flavonoids as RTK inhibitors and potential anticancer agents.

Teillet F, Boumendjel A, Boutonnat J, Ronot X. Teillet F, et al. Among authors: ronot x. Med Res Rev. 2008 Sep;28(5):715-45. doi: 10.1002/med.20122. Med Res Rev. 2008. PMID: 18080331 Review.

5

Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?

Boumendjel A, Ronot X, Boutonnat J. Boumendjel A, et al. Among authors: ronot x. Curr Drug Targets. 2009 Apr;10(4):363-71. doi: 10.2174/138945009787846416. Curr Drug Targets. 2009. PMID: 19355861 Review.

6

Iodination increases the activity of verapamil derivatives in reversing PGP multidrug resistance.

Barattin R, Gerby B, Bourges K, Hardy G, Olivares J, Boutonnat J, Arnoult C, D'Hardemare AD, Ronot X. Barattin R, et al. Among authors: ronot x. Anticancer Res. 2010 Jul;30(7):2553-9. Anticancer Res. 2010. PMID: 20682982

7

Structural requirement of arylindolylpropenones as anti-bladder carcinoma cells agents.

Martel-Frachet V, Kadri M, Boumendjel A, Ronot X. Martel-Frachet V, et al. Among authors: ronot x. Bioorg Med Chem. 2011 Oct 15;19(20):6143-8. doi: 10.1016/j.bmc.2011.08.015. Epub 2011 Aug 16. Bioorg Med Chem. 2011. PMID: 21908193

8

Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.

Valdameri G, Gauthier C, Terreux R, Kachadourian R, Day BJ, Winnischofer SM, Rocha ME, Frachet V, Ronot X, Di Pietro A, Boumendjel A. Valdameri G, et al. Among authors: ronot x. J Med Chem. 2012 Apr 12;55(7):3193-200. doi: 10.1021/jm2016528. Epub 2012 Apr 2. J Med Chem. 2012. PMID: 22449016 Free PMC article.

9

A flow cytometric assay for simultaneous assessment of drug efflux, proliferation, and apoptosis.

Barbier M, Gray BD, Muirhead KA, Ronot X, Boutonnat J. Barbier M, et al. Among authors: ronot x. Cytometry B Clin Cytom. 2004 May;59(1):46-53. doi: 10.1002/cyto.b.20004. Cytometry B Clin Cytom. 2004. PMID: 15108170 Free article.

10

Optimization of PKH67 labeling conditions for proliferation monitoring in daunorubicin-treated leukemic cells.

Barbier M, Morjani H, Muirhead KA, Ronot X, Boutonnat J. Barbier M, et al. Among authors: ronot x. Oncol Rep. 2005 Aug;14(2):553-9. doi: 10.3892/or.14.2.553. Oncol Rep. 2005. PMID: 16012744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters